Case Series on Covid Associated Mucormycosis

Abstract

Mucormycosis is a rare fungal infection. The rapid increase in the number of cases of mucormycosis during the second wave of covid lead to a new entity called Covid Associated Mucormycosis (CAM). In this case series we discuss 7 cases of CAM who presented to our hospital during the second wave of Covid. We describe their clinical features, investigations, treatment, complications and follow up. Male: Female ratio was 4:3. Mean age of presentation was 57.85. The average time of presentation of symptoms of mucormycosis after covid was 2 weeks. All of them were diabetic. Three of them had cerebral involvement. All of them underwent surgical debridement followed by antifungal therapy. The mortality rate in our study is 42.86 percentage which is compared with other studies in literature. This is the first study of its kind from a government hospital in Kerala